Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256

The effect of particle design on cellular internalization pathways

Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918

Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery

Liong, M., Lu, J., Kovochich, M., Xia, T., Ruehm, S. G., Nel, A. E., Tamanoi, F., & Zink, J. I. (2008) · ACS Nano · doi:10.1021/nn800072t · Cited by 1,968

Biocompatibility, Biodistribution, and Drug‐Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals

Lu, J., Liong, M., Li, Z., Zink, J. I., & Tamanoi, F. (2010) · Small · doi:10.1002/smll.201000538 · Cited by 1,095

Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery

Vivero-Escoto, J. L., Slowing, I. I., Trewyn, B. G., & Lin, V. S. ‐. (2010) · Small · doi:10.1002/smll.200901789 · Cited by 1,024

Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs

Lu, J., Liong, M., Zink, J. I., & Tamanoi, F. (2007) · Small · doi:10.1002/smll.200700005 · Cited by 1,012

The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function

Huang, X., Teng, X., Chen, D., Tang, F., & He, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.060 · Cited by 1,002

Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs

Xia, T., Kovochich, M., Liong, M., Meng, H., Kabehie, S., George, S., Zink, J. I., & Nel, A. E. (2009) · ACS Nano · doi:10.1021/nn900918w · Cited by 933

Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line

Meng, H., Liong, M., Xia, T., Li, Z., Ji, Z., Zink, J. I., & Nel, A. E. (2010) · ACS Nano · doi:10.1021/nn100690m · Cited by 915

Silica Particles: A Novel Drug‐Delivery System

Barbe, C., Bartlett, J. R., Kong, L., Finnie, K. S., Lin, H., Larkin, M., Calleja, S., Bush, A. J., & Calleja, G. (2004) · Advanced Materials · doi:10.1002/adma.200400771 · Cited by 858

A novel and simple preparative method for uniform-sized PLGA microspheres: Preliminary application in antitubercular drug delivery

Liu, Z., Li, X., Xiu, B., Duan, C., Li, J., Zhang, X., Yang, X., Dai, W., Johnson, H., Zhang, H., et al. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.05.085 · Cited by 32

Bactericidal impact of Ag, ZnO and mixed AgZnO colloidal nanoparticles on HRv Mycobacterium tuberculosis phagocytized by THP-1 cell lines

Jafari, A., Mosavari, N., Movahedzadeh, F., Nodooshan, S. J., Safarkar, R., Moro, R., Kamalzadeh, M., Majidpour, A., Boustanshenas, M., & Mosavi, T. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.07.010 · Cited by 32

The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine

Mahajan, K. D., & Bhattacharya, S. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266287101240214071718 · Cited by 31

Isoniazid–phytochemical conjugation: A new approach for potent and less toxic anti‐TB drug development

Swain, S. S., Paidesetty, S. K., Padhy, R. N., & Hussain, T. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13685 · Cited by 30

Biofunctionalized zinc peroxide (ZnO 2 ) nanoparticles as active oxygen sources and antibacterial agents

Bergs, C., Brück, L., Rosencrantz, R. R., Conrads, G., Elling, L., & Pich, A. (2017) · RSC Advances · doi:10.1039/c7ra06332f · Cited by 29

In vitro controlled release of Rifampicin through liquid-crystalline folate nanoparticles

Parmar, R., Misra, R. D., & Mohanty, S. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.03.051 · Cited by 28

State of the art and future directions in nanomedicine for tuberculosis

Dube, A., Lemmer, Y., Hayeshi, R. K., Balogun, M. O., Labuschagne, P. W., Swai, H., & Kalombo, L. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.846905 · Cited by 28

Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design*

Chawla, R., Jaiswal, S., & Mishra, B. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.807794 · Cited by 28

Alginate Nanoparticles: A Potential Drug Carrier in Tuberculosis Treatment

Patel, R. P., Patel, G. K., Patel, N. A., Singh, S. K., & Chittasupho, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-14100-3_11 · Cited by 27

Antibiotic Drug Delivery Systems for the Intracellular Targeting of Bacterial Pathogens

Chifiriuc, M. C., Holban, A. M., Curuțiu, C., Diţu, L.-M., Mihăescu, G., Oprea, A. E., Grumezescu, A. M., & Lazăr, V. (2016) · InTech eBooks · doi:10.5772/61327 · Cited by 26

A review on recent advances in nanomedicines for the treatment of pulmonary tuberculosis

Chaudhary, K. R., Puri, V., Singh, A., & Singh, C. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.103069 · Cited by 25

Preparation, characterization, and in-vitro cytotoxicity of nanoliposomes loaded with anti-tubercular drugs and TGF-β1 siRNA for improving spinal tuberculosis therapy

Yang, Z., Lou, C., Wang, X., Wang, C., Shi, Z., & Niu, N. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07791-8 · Cited by 25

Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities

Xia, X., Pethe, K., Kim, R., Ballell, L., Barros, D., Cechetto, J. D., Jeon, H.-K., Kim, K., & Garcia‐Bennett, A. E. (2014) · Nanomaterials · doi:10.3390/nano4030813 · Cited by 25

Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages

Sharma, P. R., Dravid, A. A., Kalapala, Y. C., Gupta, V. K., Jeyasankar, S., Goswami, A., & Agarwal, R. (2021) · Biomaterials Advances · doi:10.1016/j.msec.2021.112612 · Cited by 25

Antibiotic‐Loaded Amphiphilic Chitosan Nanoparticles Target Macrophages and Kill an Intracellular Pathogen

Trousil, J., Dal, N. K., Fenaroli, F., Schlachet, I., Kubíčková, P., Janoušková, O., Pavlová, E., Škorič, M., Trejbalová, K., Pavliš, O., et al. (2022) · Small · doi:10.1002/smll.202201853 · Cited by 24

Intracellular Degradation of Multilabeled Poly(Ethylene imine)–Mesoporous Silica–Silica Nanoparticles: Implications for Drug Release

Bergman, L., Kankaanpää, P., Tiitta, S., Duchanoy, A., Li, L., Heino, J., & Lindén, M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005879 · Cited by 24

Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte-Targeted Delivery

Afinjuomo, F., Barclay, T. G., Parikh, A. R., Chung, R., Song, Y., Nagalingam, G., Triccas, J. A., Wang, L., Liu, L., Hayball, J. D., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110555 · Cited by 24

Mesoporous Silica Nanoparticles as a Potential Platform for Vaccine Development against Tuberculosis

Montalvo-Quirós, S., Vallet‐Regí, M., Palacios, A., Anguíta, J., Prados‐Rosales, R., González, B., & Luque-Garcia, J. L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121218 · Cited by 24

Guest-host Relationship of Cyclodextrin and its Pharmacological Benefits

Alshati, F., Alahmed, T. A. A., Sami, F. M., Ali, S., Majeed, S., Murtuja, S., Hasnain, M. S., & Ansari, M. T. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128266398231027100119 · Cited by 23

Macrophages Targeted Drug Delivery as a Key Therapy in Infectious Disease

Cătoi, C. (2014) · Cited by 23

Unbiased Identification of Angiogenin as an Endogenous Antimicrobial Protein With Activity Against Virulent Mycobacterium tuberculosis

Noschka, R., Gerbl, F., Löffler, F., Kubis, J., Rodríguez, A., Mayer, D., Grieshober, M., Holch, A., Raasholm, M., Forssmann, W., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.618278 · Cited by 23

Synthesis, characterization, and efficacy of antituberculosis isoniazid zinc aluminum-layered double hydroxide based nanocomposites

Zowalaty, M. E. E., Hussein, M. Z., Arulselvan, P., Fakurazi, S., Webster, T. J., Geilich, B., & Bullo, S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s102406 · Cited by 23

In silico identification and synthesis of a multi-drug loaded MOF for treating tuberculosis

Acharya, A. P., Sezginel, K. B., Gideon, H. P., Greene, A. C., Lawson, H., Inamdar, S., Tang, Y., Fraser, A. J., Patel, K. V., Liu, C., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.024 · Cited by 22

Development of a Highly Biocompatible Antituberculosis Nanodelivery Formulation Based on Para-Aminosalicylic Acid—Zinc Layered Hydroxide Nanocomposites

Bullo, S., Arulselvan, P., Zowalaty, M. E. E., Fakurazi, S., Webster, T. J., Geilich, B., & Hussein, M. Z. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/401460 · Cited by 22

Antibiotic-Loaded Polymersomes for Clearance of Intracellular Burkholderia thailandensis

Porges, E., Jenner, D. C., Taylor, A. W., Harrison, J. S. P., Grazia, A. D., Hailes, A. R., Wright, K. M., Whelan, A. O., Norville, I. H., Prior, J. L., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c05309 · Cited by 21

A Comprehensive Study on Folate-Targeted Mesoporous Silica Nanoparticles Loaded with 5-Fluorouracil for the Enhanced Treatment of Gynecological Cancers

Almomen, A. A., & Alhowyan, A. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15030074 · Cited by 21

Breaking barriers: The potential of nanosystems in antituberculosis therapy

Canales, C. S. C., Cazorla, J. I. M., Cazorla, R. M. M., Roque‐Borda, C. A., Polinário, G., Figueroa-Banda, R., Sábio, R. M., Chorilli, M., Santos, H. A., & Pavan, F. R. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.05.013 · Cited by 21

Cyclodextrin Inclusion Complexes Loaded in Particles as Drug Carrier Systems

Fraceto, L. F., Grillo, R., & Sobarzo‐Sánchez, E. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026613666131219124847 · Cited by 21

Infectious Diseases: Need for Targeted Drug Delivery

Devarajan, P. V., Dawre, S., & Dutta, R. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_3 · Cited by 21

Nanomedicine: New Frontiers in Fighting Microbial Infections

Mehrabi, M. R., Soltani, M., Chiani, M., Raahemifar, K., & Farhangi, A. A. (2023) · Nanomaterials · doi:10.3390/nano13030483 · Cited by 20

Nanomaterials against intracellular bacterial infection: from drug delivery to intrinsic biofunction

Chen, Y., He, X., Chen, Q., He, Y., Chen, F., Yang, C., & Wang, L. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1197974 · Cited by 22

A Designed 5‐Fluorouracil‐Based Bridged Silsesquioxane as an Autonomous Acid‐Triggered Drug‐Delivery System

Giret, S., Théron, C., Gallud, A., Maynadier, M., Gary‐Bobo, M., Garcia, M., Man, M. W. C., & Carcel, C. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201301081 · Cited by 20

Cloxacillin benzathine-loaded polymeric nanocapsules: Physicochemical characterization, cell uptake, and intramammary antimicrobial effect

Araújo, R. S., Garcia, G. M., Vilela, J. M. C., Andrade, M. S., Oliveira, L. A. M., Kano, E. K., Lange, C. C., Brito, M. A. V. P., Brandão, H. D. M., & Mosqueira, V. C. F. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110006 · Cited by 20

Design and in vitro assessment of chitosan nanocapsules for the pulmonary delivery of rifabutin

Valverde-Fraga, L., Haddad, R. H., Alrabadi, N., Sánchez, S., Remuñán‐López, C., & Csaba, N. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106484 · Cited by 19

Subcellular localization and therapeutic efficacy of polymeric micellar nanoparticles encapsulating bedaquiline for tuberculosis treatment in zebrafish

Bhandari, M., Soria‐Carrera, H., Wohlmann, J., Dal, N. K., de la Fuente, J. M., Martín‐Rapún, R., Griffiths, G. W., & Fenaroli, F. (2023) · Biomaterials Science · doi:10.1039/d2bm01835g · Cited by 18

Cytosolic delivery of proteins mediated by aldehyde-displaying silica nanoparticles with pH-responsive characteristics

Wu, X., Wu, S., Yang, L., Han, J., & Han, S. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm33434h · Cited by 18

Influence of PDLA nanoparticles size on drug release and interaction with cells

Cartaxo, A. L., Costa-Pinto, A. R., Martins, A. M., Faria, S., Gonçalves, V. M. F., Tiritan, M. E., Ferreira, H., & Neves, N. M. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36563 · Cited by 18

Stimuli-Responsive Nanomachines and Caps for Drug Delivery

Kumar, N., Chen, W., Cheng, C., Deng, T., Wang, R., & Zink, J. I. (2018) · The Enzymes · doi:10.1016/bs.enz.2018.07.003 · Cited by 17

Chelating silica nanoparticles for efficient antibiotic delivery and particle imaging in Gram-negative bacteria

Muguruza, A. R., Maio, A. D., Hodges, N. J., Blair, J. M. A., & Pikramenou, Z. (2023) · Nanoscale Advances · doi:10.1039/d2na00884j · Cited by 17

Roles of Nanotechnology in Diagnosis and Treatment of Tuberculosis

Cheepsattayakorn, A., & Cheepsattayakorn, R. (2013) · Journal of Nanotechnology in Diagnosis and Treatment · doi:10.12974/2311-8792.2013.01.01.3 · Cited by 17

In Vitro Study for Comparing the Cytotoxicity of Silver and Gold Nanospheres on Raw 264.7 Murine Macrophage Cell Line

Ali, H. R. K., & Moawad, M. S. (2016) · Journal of Bacteriology & Parasitology · doi:10.4172/2155-9597.1000264 · Cited by 17

C4B32 nanocluster as a drug delivery system for nitrosourea anticancer drug: a first-principles perception

Deng, S., Jiang, Q., Wang, Y., Lu, X., Zhu, Y., Zhang, Y., & Qiang, L. (2020) · Molecular Physics · doi:10.1080/00268976.2020.1808906 · Cited by 17

Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration

Abruzzo, A., Croatti, V., Zuccheri, G., Nicoletta, F. P., Sallustio, V., Corazza, E., Vitali, B., Cerchiara, T., Luppi, B., & Bigucci, F. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.10.001 · Cited by 17

Development of a drug delivery system for thioguanine-based anticancer drugs for enhancing their effectiveness

Rajhi, A. A., Salih, W. K., Mekkey, S. M., Dhahi, H. A., Shather, A. H., Duhduh, A. A., Alamri, S., & Abbas, Z. S. (2023) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2023.111022 · Cited by 16

Review of inhalable nanoparticles for the pulmonary delivery of anti-tuberculosis drugs

Ramachandran, S., Prakash, P., Mohtar, N., Kumar, K. S., & Parumasivam, T. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2279691 · Cited by 16

Mycobacterium tuberculosis Treatment Modalities and Recent Insights

Vijayrajratnam, S., Vinod, V., Varma, S., & Biswas, R. (2014) · Current Drug Delivery · doi:10.2174/1567201811666140619121728 · Cited by 17

Stability and controlled antibiotic release from thin films embedded with antibiotic loaded mesoporous silica nanoparticles

Tamanna, T., Bulitta, J. B., Landersdorfer, C. B., Cashin, V. B., & Yu, A. (2015) · RSC Advances · doi:10.1039/c5ra22976f · Cited by 16

Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?

Abbadi, B. L., Rodrigues-Junior, V. S., Dadda, A. D. S., Pissinate, K., Villela, A. D., Campos, M. M., Lopes, L. G. D. F., Bizarro, C. V., Machado, P., Sousa, E. H. S., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00880 · Cited by 15

Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse Model

Clemens, D. L., Lee, B., Plamthottam, S., Tullius, M. V., Wang, R., Yu, C., Li, Z., Dillon, B. J., Zink, J. I., & Horwitz, M. A. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00268 · Cited by 15

Theoretical analysis of the structural and electronic properties of the interaction of boron nitride diamantane nanocrystal with the drug hydroxyurea as an anticancer drug

Muhsen, H. O., Almayyali, A. O. M., Al-Mamoori, A. Y., & Mahmood, F. F. (2021) · Journal of Molecular Modeling · doi:10.1007/s00894-021-04711-6 · Cited by 15

Nanocarrier-based interventions for the management of MDR/XDR-TB

Mustafa, S., Pai, R. S., Singh, G., & Devi, V. K. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1009076 · Cited by 15

Silica‐based matrices: State of the art and new perspectives for therapeutic drug delivery

Andreani, T., Silva, A. M., & Souto, E. B. (2014) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1322 · Cited by 15

Polyhexamethylene Biguanide and Nadifloxacin Self-Assembled Nanoparticles: Antimicrobial Effects against Intracellular Methicillin-Resistant Staphylococcus aureus

Kamaruzzaman, N. F., Pina, M. D. F., Chivu, A., & Good, L. (2018) · Polymers · doi:10.3390/polym10050521 · Cited by 15

In vitro Pharmacokinetic Cell Culture System that Simulates Physiologic Drug and Nanoparticle Exposure to Macrophages

Kutscher, H. L., Morse, G. D., Prasad, P. N., & Reynolds, J. L. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2576-9 · Cited by 14

Modeling nanoparticle delivery of TB drugs to granulomas

Grobler, A., Sierra, Z. P., & Viljoen, H. J. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.10.004 · Cited by 14

Nanoformulations and Clinical Trial Candidates as Probably Effective and Safe Therapy for Tuberculosis

Laghari, M., Darwis, Y., Memon, A. H., Khan, A. A., Abdulbaqi, I. M., & Assi, R. A. (2016) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v15i1.28 · Cited by 14

Biological macromolecules based targeted nanodrug delivery systems for the treatment of intracellular infections

Aparna, V., Shiva, M., Biswas, R., & Jayakumar, R. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.01.030 · Cited by 14

The use of nanoparticles in the treatment of infectious diseases and cancer, dental applications and tissue regeneration: a review

Nasab, A. S., Banafshe, H. R., Atapour, A., Mahabady, M. K., Akbari, M., Daraei, A., Mansoori, Y., & Hasan‐Abad, A. M. (2024) · Frontiers in Medical Technology · doi:10.3389/fmedt.2023.1330007 · Cited by 13

Antibacterial activity of rifamycins for M. smegmatis with comparison of oxidation and binding to tear lipocalin

Staudinger, T., Redl, B., & Glasgow, B. J. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.02.001 · Cited by 13

Silica Nanoparticles as a Basis for Efficacy of Antimicrobial Drugs

Lykov, A. P., Гайдуль, К. В., Гольдина, И. А., Konenkov, V. I., Va, K., Lyakhov, N. Z., & Dushkin, A. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46152-8.00025-1 · Cited by 13

Advancing Tuberculosis Chemotherapy: Targeted Nanomedicines for the Mycobacterium TB Granuloma

Singh, S. R., Makatini, M. M., Marimuthu, T., & Choonara, Y. E. (2025) · Small · doi:10.1002/smll.202506381 · Cited by 12

Innovative nanotechnology for infectious and inflammatory disease control: From diagnostics to therapeutics

Khosravi, F., Rahmani, P., & Jahanban‐Esfahlan, R. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118551 · Cited by 13

In vitro comparison of three rifampicin loading methods in a reinforced porous β-tricalcium phosphate scaffold

Yuan, J., Wang, B., Chen, H., Lu, X. F., Sun, W. Y., Wang, D., Lu, J., Zhao, J., Zhang, C., & Xie, Y. (2015) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-015-5437-z · Cited by 12

Poly(ethylene carbonate)-containing polylactic acid microparticles with rifampicin improve drug delivery to macrophages

Priemel, P. A., Wang, Y., Bohr, A., Water, J. J., Yang, M., & Nielsen, H. M. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12937 · Cited by 12

Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design

Canales, C. S. C., Cazorla, J. I. M., Cazorla, R. M. M., dos Santos, A. M., Duarte, J. L., Nunes, L. O. C., Reis, T. C., Salvador, L. C., Santos‐Filho, N. A., Sábio, R. M., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202503964 · Cited by 11

Liposome-siderophore conjugates loaded with moxifloxacin serve as a model for drug delivery against Mycobacterium tuberculosis

Ribeiro, C. M., Roque‐Borda, C. A., Franzini, M. C., Manieri, K. F., Demarqui, F. M., Campos, D. L., Machado, R. T. A., da Silva, I. C., Luiz, M. T., Filippo, L. D. D., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124050 · Cited by 11

Targeting tuberculosis infection in macrophages using chitosan oligosaccharide nanoplexes

Koli, U., Nilgiriwala, K. S., Sriraman, K., Jain, R. D., & Dandekar, P. P. (2019) · Journal of Nanoparticle Research · doi:10.1007/s11051-019-4623-1 · Cited by 11

Antiproliferative potential of Andean Berry (Vaccinium meridionaleSwartz) juice in combination with Aspirin in human SW480 colon adenocarcinoma cells

Arango-Varela, S. S., Luzardo‐Ocampo, I., Reyes‐Dieck, C., Yahia, E. M., & Celis, M. E. M. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13760 · Cited by 11

Adaptation to the intracellular environment of primary human macrophages influences drug susceptibility of Mycobacterium tuberculosis

Lanni, F., Wijnant, G.-J., Xie, M., Osiecki, P., Dartois, V. A., & Sarathy, J. P. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102318 · Cited by 11

Preparation, characterization, and in vitro evaluation of isoniazid and rifampicin‐loaded archaeosomes

Attar, A., Bakir, C., Yüce‐Dursun, B., Demir, S., Çakmakçı, E., Danış, Ö., Birbir, M., & Ogan, A. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13066 · Cited by 11

Glycosylated Nanoparticles Derived from RAFT Polymerization for Effective Drug Delivery to Macrophages

Rushworth, J. L., Montgomery, K. S., Cao, B., Brown, R., Dibb, N. J., Nilsson, S. K., Chiefari, J., & Fuchter, M. J. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00529 · Cited by 11

Introduction to Chronic Respiratory Diseases: A Pressing Need for Novel Therapeutic Approaches

Chan, Y., Ng, S. W., Liew, H. S., Pua, L. J. W., Soon, L., Lim, J. S., Dua, K., & Chellappan, D. K. (2021) · Springer eBooks · doi:10.1007/978-981-33-6850-7_2 · Cited by 11

Macromolecular Conjugate and Biological Carrier Approaches for the Targeted Delivery of Antibiotics

Tram, N. D. T., & Ee, P. L. R. (2017) · Antibiotics · doi:10.3390/antibiotics6030014 · Cited by 11

Exploring the potential of metalloporphyrin-like C54N4 fullerene (TM-PC60F) nanoclusters as new drug delivery platform for 5-fluorouracil: A DFT and QTAIM study

Marlina, L. A., Hutama, A. S., Arief, I., Mazaya, M., Syafarina, I., & Saputri, W. D. (2024) · Diamond and Related Materials · doi:10.1016/j.diamond.2024.111267 · Cited by 10

Potential of zinc carbide 2D monolayers as a new drug delivery system for nitrosourea (NU) anti-cancer drug

Fahad, I. H., Sadoon, N., Kadhim, M. M., Alhussainy, A. A., Hachim, S. K., Abdulhussain, M. A., Abdullaha, S. A. H., & Rheima, A. M. (2022) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2022.113927 · Cited by 10

Current therapeutic delivery approaches using nanocarriers for the treatment of tuberculosis disease

Biswas, B., Misra, T. K., Ray, D., Majumder, T., Bandyopadhyay, T. K., & Bhowmick, T. K. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123018 · Cited by 10

Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays

Subramaniam, S., Joyce, P., Ogunniyi, A. D., Dube, A., Sampson, S. L., Lehr, C., & Prestidge, C. A. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00613 · Cited by 10

The electronic appetite rating system (EARS): a portable computerised method of continuous automated monitoring of motivation to eat and mood

King, N. A., Lawton, C. R., Delargy, H. J., Smith, F., & Blundell, J. E. (1997) · QUT ePrints (Queensland University of Technology) · Cited by 10

Synthesis and Functionalization of Ordered Large‐Pore Mesoporous Silica Nanoparticles for Biomedical Applications

Chiu, H., Leonhardt, H., & Bein, T. (2017) · Chemie Ingenieur Technik · doi:10.1002/cite.201700021 · Cited by 9

Boron carbide nanotube as targeted drug delivery system for melphalan anticancer drug

Zadeh, F. A., Jasim, S. A., Ansari, M. J., Bokov, D. O., Yasin, G., Thangavelu, L. P., & Derakhshandeh, M. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.118796 · Cited by 9

B3O3 monolayer an emerging 2D material in as a carrier for anticancer delivery system

Kadhim, M. M., Sahib, A. S., Hachim, S. K., Taban, T. Z., Abdullaha, S. A., & Rheima, A. M. (2022) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2022.127158 · Cited by 9

A novel solventless coating method to graft low-molecular weight polyethyleneimine on silica fine powders

Murillo-Cremaes, N., López‐Aranguren, P., Vega, L. F., Saurina, J., Roig, A., & Domingo, C. (2014) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.27297 · Cited by 10

Injectable controlled‐release systems for the prevention and treatment of infectious diseases

Kunkel, A. A., & McHugh, K. J. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37615 · Cited by 9

Synthesis of bio-stabilized silver nanoparticles using Roccella montagnei, their anticandidal capacities & potential to inhibit the virulence factors in fluconazole-resistant Candida albicans

Bharti, S., Singh, B., Kumar, S., Kumar, R., & Kumar, J. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-03928-w · Cited by 8

Nano-strategies used for combatting the scourge of tuberculosis infections

Fang, R., Jin, Y., Kong, W., Wang, H., Wang, S., Li, X., Xing, J., Zhang, Y., Yang, X., & Song, N. (2024) · Discover Immunity. · doi:10.1007/s44368-024-00007-y · Cited by 8

Fluorescence & Bioluminescence in the Quest for Imaging, Probing & Analysis of Mycobacterial Infections

Trousil, J., Ulmann, V., & Hrubý, M. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0296 · Cited by 8

Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections

Shin, S., Kwon, S., & Yeo, Y. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03188-z · Cited by 8

Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance

Kiani, M. H., Imran, M., Raza, A., & Shahnaz, G. (2020) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-020-00337-w · Cited by 8

Nanoparticles: Scope in Drug Delivery

Tanwar, M., Meena, J., & Meena, L. S. (2014) · Wiley eBooks · doi:10.1002/9781118774052.ch14 · Cited by 8

Inspection the potential of B3O3 monolayer as a carrier for flutamide anticancer delivery system

Talab, M. B., muttashar, H. H., Faraj, J., Abdullaha, S. A. H., Hachim, S. K., Adel, M., Kadhim, M. M., & Rheima, A. M. (2022) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2022.113886 · Cited by 7

Mesoporous Organosilica Nanoparticles to Fight Intracellular Staphylococcal Aureus Infections in Macrophages

Jambhrunkar, M., Maghrebi, S., Doddakyathanahalli, D., Wignall, A. D., Prestidge, C. A., & Bremmell, K. E. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041037 · Cited by 7

Lipids Extracted from Mycobacterial Membrane and Enveloped PLGA Nanoparticles for Encapsulating Antibacterial Drugs Elicit Synergistic Antimicrobial Response against Mycobacteria

Pu, X., Wang, Y., Wang, X., Sang, X., Jiang, M., Qi, D., Zhao, X. H., Chen, R., Li, J., Liu, X., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01001 · Cited by 7

Functionalized Antibacterial Nanoparticles for Controlling Biofilm and Intracellular Infections

Viswanathan, A., Jayakumar, R., & Biswas, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-06115-9_10 · Cited by 7

Nanotheranostic management of drug-resistant tuberculosis

Dustachkeer, V. N. A., Nirmal, C. R., Rajadas, S. E., Saadhali, S. A., Kannayan, S., & Padmanaban, V. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819985-5.00004-8 · Cited by 7

Nanoparticle-Based Inhalation Therapy for Pulmonary Diseases

Yadav, D., Wairagu, P. M., Kwak, M., & Jin, J.-O. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220803103039 · Cited by 7

Enhancing Therapeutic Efficacy against Brucella canis Infection in a Murine Model Using Rifampicin-Loaded PLGA Nanoparticles

Hernández-Giottonini, K. Y., Arellano-Reynoso, B., Rodríguez-Córdova, R. J., de la Vega-Olivas, J., Aparicio, E. D., & Lucero‐Acuña, A. (2023) · ACS Omega · doi:10.1021/acsomega.3c07892 · Cited by 7

A DFT study on antimonene as a drug delivery vehicle for carmustine, lomustine and nitrosourea anticancer drugs

Khalid, S., Majeed, A., Bano, N., Ali, S. M., Ashraf, N., Gul, M., & Khan, M. I. (2024) · Molecular Physics · doi:10.1080/00268976.2024.2413008 · Cited by 6

Polylactide-Co-Glycolide Nanoparticles of Antitubercular Drugs: Formulation, Characterization and Biodistribution Studies

Chawla, R., Solanki, H. S., Kheruka, S. C., Gambhir, S., Dube, V., Aggarwal, L. M., & Mishra, B. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.88 · Cited by 6

pH-responsive microparticles of rifampicin for augmented intramacrophage uptake and enhanced antitubercular efficacy

Lokhande, A. S., Panchal, F. H., Munshi, R., Madkaikar, M. R., Malshe, V. C., & Devarajan, P. V. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122729 · Cited by 6

Nanoparticle theranostics for respiratory diseases: advances and challenges in asthma, lung cancer, and tuberculosis

Feyzbakhsh, H. (2025) · Egyptian Journal of Bronchology · doi:10.1186/s43168-025-00507-x · Cited by 5

pH‐Responsive Isoniazid‐Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice

Hwang, A., Lee, B., Clemens, D. L., Dillon, B. J., Zink, J. I., & Horwitz, M. A. (2015) · Small · doi:10.1002/smll.201500937 · Cited by 90

Targeting intracellular mycobacteria using novel antibiotic-loaded nanoparticlesPreprint

Agarwal, P., Burnage, H., Dallmann, R., Perrier, S., & Unnikrishnan, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.14.725169

Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles

Tenland, E., Pochert, A., Krishnan, N., Rao, K. U., Kalsum, S., Braun, K., Glegola-Madejska, I., Lerm, M., Robertson, B. D., Lindén, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212858 · Cited by 96

Mycobacterial Lipid-Coated Mesoporous Silica Nanoparticles Enable “Trojan Horse” Delivery of Isoniazid for Enhanced Intracellular Mycobactericidal Activity

Wu, H., Pu, X., Wang, X., Liu, G., Ren, T., & Yang, J. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c11062 · Cited by 3

Tuberculosis: pH‐Responsive Isoniazid‐Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice (Small 38/2015)

Hwang, A., Lee, B., Clemens, D. L., Dillon, B. J., Zink, J. I., & Horwitz, M. A. (2015) · Small · doi:10.1002/smll.201570235 · Cited by 9